| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/23/2005 | EP1066261B1 Pyridine derivative and pharmaceutical containing the same |
| 11/23/2005 | EP1060744B1 Preventives/remedies for osteoporosis |
| 11/23/2005 | EP1058547B1 Pharmaceutical compositions containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1h-indol-4-yl]oxy]acetate |
| 11/23/2005 | EP1037624B1 Use of conjugated linoleic acid for treating type ii diabetes |
| 11/23/2005 | EP1025850B1 Isoflavone-containing compositions |
| 11/23/2005 | EP1023284B1 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds |
| 11/23/2005 | EP1021402B1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 11/23/2005 | EP1001797B9 Soya extract, process for its preparation and pharmaceutical composition |
| 11/23/2005 | EP0988309B1 C-4''-substituted macrolide derivatives |
| 11/23/2005 | EP0938474B1 Cyclopropylindole compounds and their use as prodrugs |
| 11/23/2005 | EP0934263B1 Non-immunosuppressant fkbp rotamase inhibitors |
| 11/23/2005 | EP0906088B1 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 11/23/2005 | EP0869789B1 Antiviral agent |
| 11/23/2005 | EP0837939B1 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 11/23/2005 | EP0781128B1 Clotrimazole metabolites in the treatment of sickle cell disease |
| 11/23/2005 | EP0778780B1 Capsular polysaccharide immunomodulator |
| 11/23/2005 | EP0662128B1 Methods and compositions for controlling translation of hcv proteins |
| 11/23/2005 | CN1701075A Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| 11/23/2005 | CN1701068A Novel compounds and their use |
| 11/23/2005 | CN1701061A New compounds for the inhibition of rotamases and use thereof |
| 11/23/2005 | CN1701059A Chemotherapeutic agents |
| 11/23/2005 | CN1700934A Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 11/23/2005 | CN1700926A Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition |
| 11/23/2005 | CN1700924A Hypotensive agent and method for producing the same |
| 11/23/2005 | CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 11/23/2005 | CN1700922A 3, 10, and 12a substituted tetracycline compounds |
| 11/23/2005 | CN1700921A Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 11/23/2005 | CN1700920A Phophylactic and therapeutic use of hydroxysteroids |
| 11/23/2005 | CN1700919A Method for treating severe heart failure and medicament therefor |
| 11/23/2005 | CN1700918A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 11/23/2005 | CN1700917A Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent |
| 11/23/2005 | CN1700916A Use of HIV-protease inhibitors to block cell migration and/or invasion, tissue inflitration and oedema formation |
| 11/23/2005 | CN1700915A Biologic skin repair and enhancement |
| 11/23/2005 | CN1700914A The prevention and treatment for inflammatory disease in oral-cavity mucosa |
| 11/23/2005 | CN1700913A Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 11/23/2005 | CN1700912A Choline ascorbate formulations |
| 11/23/2005 | CN1700911A Combination drug |
| 11/23/2005 | CN1700910A Controlled release tablets of metformin |
| 11/23/2005 | CN1700909A Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 11/23/2005 | CN1700906A Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
| 11/23/2005 | CN1700859A Nodulisporic acid derivative spot-on formulations for combating parasites |
| 11/23/2005 | CN1699390A New C-glycoside derivation and its titivating use |
| 11/23/2005 | CN1699385A Crystal form of adefovir dipivoxil |
| 11/23/2005 | CN1699383A Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 11/23/2005 | CN1699350A Processes and intermediates for preparing anti-cancer compounds |
| 11/23/2005 | CN1699349A Method and reagents for N-alkylating ureides |
| 11/23/2005 | CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation |
| 11/23/2005 | CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 11/23/2005 | CN1699343A Polymorphs of donepezil hydrochloride and process for production |
| 11/23/2005 | CN1699342A New hydroxyindoles, their use as phosphodiesterase 4 inhibitors and method for producing same |
| 11/23/2005 | CN1699331A Process for the synthesis of (is)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane and uses thereof |
| 11/23/2005 | CN1698834A Chinese medicinal capsule for treating apoplexy and its preparation method |
| 11/23/2005 | CN1698647A Fat-binding polymers |
| 11/23/2005 | CN1698646A Medicine composition for treating atrophic gastritis |
| 11/23/2005 | CN1698645A Compound medicine for treating cold |
| 11/23/2005 | CN1698644A Ribavirin orally disintegrating tablet and preparation method thereof |
| 11/23/2005 | CN1698643A Cidofovir liposome and preparation method thereof |
| 11/23/2005 | CN1698642A Baicalin soft capsule and preparation method thereof |
| 11/23/2005 | CN1698641A Soft capsule containing Clarithromycin and preparation method thereof |
| 11/23/2005 | CN1698640A Compound powder of Roxithromycin and ambroxol hydrochloride sustained adequate for children, its prescription and preparation method |
| 11/23/2005 | CN1698639A Compound preparation containing oxygen albendazole and avermectins deworming drugs |
| 11/23/2005 | CN1698638A Breviscapine orally disintegrating tablet and preparation method thereof |
| 11/23/2005 | CN1698637A Powder injection of macrolides or N-phenyl pyrazoles deworming drug |
| 11/23/2005 | CN1698636A Mixing method of antiparasitic preparation for animals |
| 11/23/2005 | CN1698635A Compound powder preparation containing hydrochloric Albendazole and other antiparasitics |
| 11/23/2005 | CN1698634A Breviscapine microcapsule and preparing process thereof |
| 11/23/2005 | CN1698633A Glycyrrhizin drop pills and preparation method thereof |
| 11/23/2005 | CN1698632A Enteric coated preparation containing notoginseng panaxtrol saponin, its preparation method and application thereof |
| 11/23/2005 | CN1698631A Glycerrhizic diammonium powder injection and preparation method thereof |
| 11/23/2005 | CN1698630A Notoginsen triterpenes microcapsule and preparation method thereof |
| 11/23/2005 | CN1698629A Notoginsen triterpenes oral rapid release preparation |
| 11/23/2005 | CN1698628A Wipe-off and recovery treatment lotion and preparation method thereof |
| 11/23/2005 | CN1698627A Rhodiola root glycosides injection for treating cardiovascular/cerebrovascular diseases and preparation method thereof |
| 11/23/2005 | CN1698626A Skin beautifying agent and food with heath caring and beautifying function |
| 11/23/2005 | CN1698625A Proportioning and preparing method of glycerose fructose composite raw material medicine |
| 11/23/2005 | CN1698624A Compound electrolytic fructose injection |
| 11/23/2005 | CN1698623A Dispersed composition of anti-hepatitis B virus drugs in non-crystalline form and pharmaceutical preparation thereof |
| 11/23/2005 | CN1698622A Essentiale injection without hemolysis effect and composition thereof |
| 11/23/2005 | CN1698621A Highly concentrated solution of finasteride and purposes thereof |
| 11/23/2005 | CN1698620A Cucurbitacin emulsion capable of filtering out and eliminating bacteria and preparation method thereof |
| 11/23/2005 | CN1698619A Oleanolic acid preparation, its formula and preparing method thereof |
| 11/23/2005 | CN1698618A Double layer tablet of artesunate and hydrochloric amodiaquine and preparation method thereof |
| 11/23/2005 | CN1698617A Doxofylline freeze dried injection |
| 11/23/2005 | CN1698616A Dipyridamole cyclodextrin, inclusion compound of cyclodextrin derivant and preparation method thereof |
| 11/23/2005 | CN1698615A Suppository containing prazosin hydrochloride, its preparation method and application |
| 11/23/2005 | CN1698614A Gatifloxacin soft capsule and preparation method thereof |
| 11/23/2005 | CN1698613A Nalmefene powder injection preparation and preparing method thereof |
| 11/23/2005 | CN1698612A Nanometer vauqueline liposome transdermal spray agent, its preparation method and application thereof |
| 11/23/2005 | CN1698611A Nanometer vauqueline liposome and preparation method thereof |
| 11/23/2005 | CN1698610A Application of quinolines alkaloid in preparation of hepatitis B virus resisting medicine |
| 11/23/2005 | CN1698609A Pitavastatin soluble tablet composition and preparation method thereof |
| 11/23/2005 | CN1698608A Nicotinic acid controlled releasing tablet and preparation method thereof |
| 11/23/2005 | CN1698607A Paracetamol pseudoephedrine hydrochloride and cholrphenamine maleate oral cavity disintegration tablet for treating cold and preparation method thereof |
| 11/23/2005 | CN1698606A Application of quinolizidine kind alkaloid in preparation of hepatitis B virus resisting medicine |
| 11/23/2005 | CN1698605A Externally used lotion of compound matrine effervescence tablet |
| 11/23/2005 | CN1698604A Beta-cyclodextrin / amoxicillin inclusion compound and its composition with clavulanic kalium and preparation thereof |
| 11/23/2005 | CN1698603A Pharmaceutical composition |
| 11/23/2005 | CN1698602A Usage of pyrazoline derivant in the drug preparation for preventing and/or treating cell breeding disease |
| 11/23/2005 | CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 11/23/2005 | CN1698600A Vitamin C composition containing amino acids |